VALIDATION IMAGES
Paraformaldehyde-fixed and paraffin-embedded Human Colon Cancer tissue incubated with ADAR (9F2) Monoclonal Antibody (bsm-54222R) at 1:100, overnight at 4°C, followed by a conjugated secondary antibody and DAB staining. Counterstained with hematoxylin.
IF(ICC) staining with ADAR (9F2) Monoclonal Antibody (bsm-54222R) at 1:100 in Hela cells (green). The nuclear counterstain is DAPI (blue). Cells were fixed in paraformaldehyde, permeabilized with 0.25% Triton X100/PBS.
Lane 1: SiHa Cells; Probed with ADAR (9F2) Monoclonal Antibody (bsm-54222R) at 1:500 overnight at 4°C followed by a conjugated secondary antibody for 60 minutes at 37°C.
Paraformaldehyde-fixed and paraffin-embedded Human Kidney tissue incubated with ADAR (9F2) Monoclonal Antibody (bsm-54222R) at 1:100, overnight at 4°C, followed by a conjugated secondary antibody and DAB staining. Counterstained with hematoxylin.
Paraformaldehyde-fixed and paraffin-embedded Human Lung Cancer tissue incubated with ADAR (9F2) Monoclonal Antibody (bsm-54222R) at 1:100, overnight at 4°C, followed by a conjugated secondary antibody and DAB staining. Counterstained with hematoxylin.
Paraformaldehyde-fixed and paraffin-embedded Human Pancreas tissue incubated with ADAR (9F2) Monoclonal Antibody (bsm-54222R) at 1:100, overnight at 4°C, followed by a conjugated secondary antibody and DAB staining. Counterstained with hematoxylin.